Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
-
-
Episode 23: Clinical Applications of Biomarkers and Large-Scale Collaborative Research with Charles Adler
-
FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials for Parkinson’s and Related Diseases
-
Episode 22: Investigating Light Therapy For Sleep and Motor Function in People with PD with Beatrix Feigl
-
What We Fund: $69.1M Toward Novel Efforts to Improve Mobility and Target Cellular Mechanisms Underlying PD
-
Episode 21: The Autophagy-Lysosomal Pathway and Development of Relevant PD Biomarkers with Zhenyu Yue
-
Join the Study that's Changing Everything
The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.
Patients First
Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
